The question when it comes to competitive sports is, which of these DSDs confer male physical advantage onto the individual?
As an example, though we can speculate with some now quite strong evidence on these two Olympic boxers, perhaps it's best to look at an athlete whose DSD is already known and confirmed: Caster Semenya, who won gold in the Women's 800m of the 2016 Olympics in Rio.
Because of a ruling published by the Court of Arbitration for Sport, we know that Semenya has 5-alpha reductase deficiency (5-ARD), a male-specific (XY) DSD that, due to a recessive gene mutation, impairs the conversion of testosterone to DHT such that the penis is underdeveloped and the testes typically remain internal to the body.
Newborns with 5-ARD may, in the absence of sex testing, be erroneously observed to be female, and have this written on their birth documentation. This is what happened with Semenya.
However, the testes are still functional. Individuals with 5-ARD go through male puberty, produce testosterone in the normal male range, and in athletic competition, will therefore have male physical advantage.
In response to Semenya's case, the IAAF (now World Athletics) instituted a rule change so that 5-ARD individuals, and others with DSDs that are known to confer male performance advantage, are by default deemed ineligible to compete in women's events.
That is: on the basis that being male is not a talent, they chose policy that does not reward male physical advantage in competitions that should be about celebrating female athletic excellence.
So I think this isn't really about if sex or gender can be thought of as a spectrum, but what policy decisions, regarding DSDs, need to be made to ensure fairness in women's sport. And in the case of contact sports like boxing, safety as well.